Status:
COMPLETED
Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia
Lead Sponsor:
Mỹ Đức Hospital
Conditions:
Severe Pre-Eclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
Pregnant women diagnosed with pre-eclampsia with severe features will be treated with magnesium sulfate to prevent seizures. Magnesium sulfate will be administered according to My Duc Hospital's proto...
Detailed Description
This observational, longitudinal, prospective case-series aims to assess serum magnesium concentrations at specific times in pregnant women treated with magnesium sulfate for pre-eclampsia with severe...
Eligibility Criteria
Inclusion
- Pregnant women
- Aged ≥ 18
- Diagnosed with pre-eclampsia with severe features, with or without chronic hypertension, as defined by the American College of Obstetricians and Gynecologists (ACOG) diagnosis criteria.
- Provision of written informed consent to participate as shown by a signature on the patient consent form.
Exclusion
- Impaired renal function (eGFR \< 60 mL/min/ 1,73 m2 or oliguria )
- Occurrence of eclampsia before magnesium sulfate administration
- Known hypersensitivity to the drug,
- Severe myasthenia, atrioventricular block
- A diminished level of consciousness.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05283473
Start Date
March 15 2022
End Date
March 30 2024
Last Update
January 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
My Duc Hospital
Ho Chi Minh City, Vietnam